Zaniewski Bilski Sp. z o.o.

At Zaniewski Bilski Sp. z o.o. in Olsztyn, clinical research in Digestive System Diseases focuses on erosive esophagitis linked to gastroesophageal reflux disease. These studies are designed to compare and confirm the effectiveness of new treatment approaches for healing and maintaining control of this condition.

• Evaluating therapies for healing erosive esophagitis caused by GERD
• Assessing treatment options for maintaining long-term healing
• Comparing new medicines with established acid-reducing treatments

The site’s work in this area supports better care for patients with reflux-related damage to the esophagus and helps clarify which therapies may offer stronger symptom control and healing.

Clinical trials in Immune System Diseases at this research site are centered on moderately to severely active ulcerative colitis and moderately to severely active Crohn’s disease. The research is aimed at testing new therapies that can help induce and maintain remission in these chronic inflammatory conditions.

• Studying treatments for ulcerative colitis to reduce inflammation and improve remission rates
• Investigating therapies for Crohn’s disease with the goal of better disease control
• Comparing active treatment with placebo in both induction and maintenance settings

These trials reflect a strong focus on inflammatory bowel disease research, with attention to both adult and adolescent patients and the need for durable, effective treatment strategies.